Meeting
2015 ASCO Annual Meeting
Investigation of intrapatient heterogeneity in the tumor infiltrating T cell repertoire in patients with metastatic melanoma treated with pembrolizumab.
Authors
Rodrigo Ramella Munhoz
Memorial Sloan Kettering Cancer Center, New York, NY
Rodrigo Ramella Munhoz , Taha Merghoub , Ryan O Emerson , Margaret K. Callahan , Jedd D. Wolchok , Michael Andrew Postow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Melanoma/Skin Cancers
Citation
J Clin Oncol 33, 2015 (suppl; abstr 9075)
DOI
10.1200/jco.2015.33.15_suppl.9075
Abstract #
9075
Poster Bd #
318
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Investigation of the immune infiltrate of melanoma metastases under immune checkpoint inhibition.
First Author: Jessica Cecile Hassel
Poster
2023 ASCO Annual Meeting
Immune infiltrates in metastatic uveal melanoma liver metastases and associations with clinical outcomes.
First Author: Katherine Emilie Rhoades Smith
Poster
2015 ASCO Annual Meeting
T-cell therapy in metastatic melanoma: TIL 1383I TCR transduced T cells after infusion and activity in vivo.
First Author: Courtney Regan
Poster
2015 ASCO Annual Meeting
Bim as a predictive T-cell biomarker for response to anti-PD-1 therapy in metastatic melanoma (MM).
First Author: Roxana Stefania Dronca